Delivery Order SPE2DB22D1106-SPE2DB25FDVH7
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,914.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,718,108 units of Ondansetron HCL 4 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of December 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $5,001.12, is for the delivery of 4,564,560,290 units of Ondansetron ODT 4 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $6,387.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,754,560 units of Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award, valued at $9,996.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,134,913 units of Ondansetron ODT 4 mg Tablets in 30-count packages. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This federal contract award, worth $1,440.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,689,323 units of Ondansetron ODT 4 mg tablets in 30-count packs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This federal contract award to Amerisourcebergen Drug Corporation (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The specific contract award is for the supply of 4,565,468,004 units of...
This federal contract award, valued at $1,196.53, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg Tablets in quantities of 30. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award, valued at $20,410.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,568,235,242 units of 4 mg Ondansetron HCL tablets, with a period of performance through May 14, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,228.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2006|SPE2DB25FW0LP) for the supply of 4,568,092 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price arrangement. This award is not associated with a set-aside program and is part of a...
This federal contract award, valued at $4,255.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,927,117 units of Ondansetron ODT 8 mg tablets, with a performance period ending on April 16, 2025. This is a firm-fixed-price delivery order contract, and it is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...